Electrocardiographic (ECG) left bundle branch block (LBBB) is associated with left ventricular hypertrophy (LVH), but its relation to left ventricular (LV) geometry and function in hypertensive patients with ECG LVH is unknown. Echocardiograms were performed in 933 patients (548 women, mean age 6677 years) with essential hypertension and LVH by baseline ECG in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. LBBB, defined by Minnesota code 7.1, was present in 47 patients and absent in 886 patients. Patients with and without LBBB were similar in age, gender, body mass index, blood pressure, prevalence of diabetes, and history of myocardial infarction. Despite similarly elevated mean LV mass (126725 vs 124726 g/m 2 ) and relative wall thickness (0.4170.07 vs 0.4170.07, P ¼ NS), patients with LBBB had lower LV fractional shortening (3076 vs 3476%), ejection fraction (56710 vs 6178%), midwall shortening (1472 vs 1672%), stress-corrected midwall shortening (90713 vs 97713%) (all Po0.001), and lower LV stroke index (3877 vs 4279 ml/m 2 ) (Po0.05). Patients with LBBB also had reduced LV inferior wall and lower mitral E/A ratio (0.7570.18 vs 0.8770.38) (all Po0.05). The above univariate results were confirmed by multivariate analyses adjusted for gender, age, blood pressures, height, weight, body mass index, heart rate, and LV mass index. Among hypertensive patients at high risk because of ECG LVH, the presence of LBBB identifies individuals with worse global and regional LV systolic function and impaired LV relaxation without more severe LVH by echocardiography.
Electrocardiographic (ECG) left bundle branch block (LBBB) is associated with left ventricular hypertrophy (LVH), but its relation to left ventricular (LV) geometry and function in hypertensive patients with ECG LVH is unknown. Echocardiograms were performed in 933 patients (548 women, mean age 6677 years) with essential hypertension and LVH by baseline ECG in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. LBBB, defined by Minnesota code 7.1, was present in 47 patients and absent in 886 patients. Patients with and without LBBB were similar in age, gender, body mass index, blood pressure, prevalence of diabetes, and history of myocardial infarction. Despite similarly elevated mean LV mass (126725 vs 124726 g/m 2 ) and relative wall thickness (0.4170.07 vs 0.4170.07, P ¼ NS), patients with LBBB had lower LV fractional shortening (3076 vs 3476%), ejection fraction (56710 vs 6178%), midwall shortening (1472 vs 1672%), stress-corrected midwall shortening (90713 vs 97713%) (all Po0.001), and lower LV stroke index (3877 vs 4279 ml/m Introduction Electrocardiographic (ECG) left bundle branch block (LBBB) is associated with left ventricular hypertrophy (LVH). 1 Several studies have shown associations between LBBB and left ventricle systolic and diastolic dysfunction in otherwise healthy individuals. 2, 3 However, it is unknown whether LBBB is associated with additional LV geometric and functional abnormalities in hypertensive patients with ECG-defined LVH.
The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study was a prospective trial to compare the efficacy of losartan vs atenolol-based treatment in reducing the rate of cardiovascular morbidity and mortality in hypertensive patients. The LIFE study enrolled patients with essential hypertension and ECG-defined LVH. 4, 5 The current study was undertaken to evaluate the association of LBBB with LV geometric and functional abnormalities in patients with hypertension and ECG LVH enrolled in the LIFE echocardiography substudy.
Methods

Subjects
All subjects in this study were from the LIFE echocardiography substudy. 6 The LIFE echo substudy was undertaken to evaluate the effects of losartan-vs atenolol-based treatment on LV geometry and function in a subset of 960 patients (mean age 66 years (range 55-81)) with systemic hypertension (arterial pressure 160-200/95-115 mmHg after placebo run-in) and ECG LVH, constituting 11% of the entire LIFE population. 5, 6 The patient exclusion criteria of the LIFE study included certain cardiovascular conditions and noncardiac diseases that might have limited long-term survival of the patient, or increase the likelihood of nonadherence to study medication. 5, 6 All participants in this study had baseline and follow-up ECGs and echocardiograms. The ECG diagnostic criteria for LVH were Cornell voltage Â QRS duration X2440 mV Â ms or modified Sokolow-Lyon criteria SV1 þ RV5/RV6438 mV. 5, 6 LBBB was defined according to the standard ECG criteria of Minnesota code 7.1 as follows: QRS duration 0.12 s or greater in I, II, and III, and R-peak duration 0.06 s or more in any of I, II, aVL, V5, or V6. The current study included all (n ¼ 933) patients having both the needed ECG results and echocardiographic LV structural and functional parameters. The characteristics of the study population are shown in Table 1 .
Echocardiographic methods and performance protocol
Echocardiograms were performed in 47 selected echocardiography centres in Denmark, Finland, Iceland, Norway, Sweden, the United Kingdom, and the United States using high-quality commercially available echocardiographs with 3.0. to 3.5 and 2.0 to 2.5 MHz probes and VHS or Super-VHS video recorders. Echocardiographic methods and performance protocol were based on procedures used as in previous studies 7, 8 and have been described in detail. 6, 9, 10 The echocardiograms were sent to Cornell Medical Center in New York City for blinded interpretation by experienced physicians, and blinded verification, and correction of measurements if necessary, by highly experienced investigators.
Echocardiographic measurements
The measurements were made blindly using computerized review stations (Digisonics, Inc., Houston, TX, USA) equipped with NTSC or PAL standard VCRs and digitizing tablet and monitor screen overlay for calibration and performance of each measurement. [8] [9] [10] Linear LV internal dimension and interventricular septal and posterior wall thickness were measured at end-diastole and end-systole according to American Society of Echocardiography recommendations. 11, 12 Left atrial end-systolic dimension was measured from the trailing edge of the posterior aortic-anterior left atrial complex to avoid erroneously including the variable size of the connective tissue-filled space between these structures in atrial size. 13 The aortic annular and root diameter were measured at end-diastole using the same method as in previously published papers. 14, 15 Pulse-wave Doppler recordings of transmitral flow velocities were obtained by placing the sample volume between the tips of the mitral leaflets. Transmitral flow measurements included peak early LV filling velocity (E-wave), peak atrial filling velocity (A-wave), and their ratio (E/A ratio); and the deceleration time and pressure half-time of early diastolic transmitral flow (E-wave). Pulse-wave Doppler recordings of isovolumic relaxation time (IVRT) were obtained by placing the sample volume between the anterior mitral leaflet and LV outflow tract from the closure spike of the aortic valve to onset of the mitral flow. 16 Pulse-wave Doppler recordings of the left ventricular outflow tract (LVOT) velocity were obtained by placing the sample volume at the level of aortic annulus, and the LVOT velocity Doppler spectral patterns were traced electronically to measure the time-velocity integral (TVI) of LVOT; the latter was multiplied by the calculated aortic annular cross-sectional area, which is defined as p Â (LVOT radius) 2 to derive LV stroke volume. Cardiac output was calculated as stroke volume Â heart rate. 17, 18 Heart rates were measured at the same time from Doppler spectral recordings. Measurements of two to three cardiac cycles were averaged.
Calculation of derived variables
From echocardiographic end-diastolic LV dimensions, LV mass was calculated by an anatomically validated formula (r ¼ 0.90) 19 with good inter-study reproducibility (r ¼ 0.93). 20 LV mass index was calculated as the ratio LV mass/body surface area. Relative wall thickness was calculated as diastolic posterior LV wall thickness/LV internal radius. 21 LVH was defined by LV mass index 4116 g/m 2 in men or 4104 g/m 2 in women. 7 Increased relative wall thickness was defined by relative wall thickness 40.43, the 97.5 percentile in normal subjects. 22 Normal LV geometry was identified when LV mass index and relative wall thickness were both normal. Concentric LVH was defined by abnormally increased values for both LV mass index and relative wall thickness. Eccentric LV hypertrophy was defined by abnormally increased LV mass index LV systolic fractional shortening, ejection fraction, and circumferential end-systolic wall stress (ESS) were calculated by standard methods. 24, 25 Stroke volume from linear LV dimensions was calculated as the difference between LV end-diastolic and end-systolic volume by the method of Teichholz et al 26 and was used to calculate LV ejection fraction. The ejection fraction was also calculated from the wall motion scores of all LV wall segments. Ejection fractions from both LV linear dimension and twodimensional wall motion scores have been shown to predict prognosis in a population-based sample. 27 
Echocardiographic evaluation of LV function
Global LV systolic function was accessed by fractional shortening, ejection fraction, and cardiac output. Regional LV wall motion was assessed based on motion and thickening of individual LV wall segments. In this study, the LV was divided into 14 segments at basal, midcavity, and apical LV level, respectively. 28 Based on the motion and thickening of each segment, wall motion was scored on a scale from normal to dyskinetic. To derive an estimate of overall LV ejection fraction from regional wall motion score, the following score values were assigned to each segment: normal motion ¼ 4.5, mildly hypokinetic ¼ 3.5, moderately hypokinetic ¼ 2.5, severely hypokinetic ¼ 1.5, akinetic ¼ 0, and dyskinetic ¼ À1.0.
Diastolic LV filling function was evaluated by the following Doppler parameters: peak E-wave velocity, peak A-wave velocity, E/A ratio, E-wave deceleration time, and IVRT. E/A ratio o1 was considered low in the age group of LIFE study. 10 Ewave deceleration time o150 ms was considered abnormally short 29 and 4250 ms was considered abnormally prolonged. 30 IVRT 4100 ms was considered pathologic. 16, 30 LV diastolic function was considered to be normal when E/A ratio, E-wave deceleration time, and IVRT were all within normal ranges.
Statistical analysis
SPSS statistical software version 11.0 (SPSS, Inc., Chicago, IL, USA) was used for data analysis. Results were presented as mean7s.d. LV geometric measurements, Doppler parameters, and derived variables were compared between patient groups with and without LBBB by independent samples ttest, and the results were further confirmed by nonparametric two samples test. The significance of difference between categorical variables was accessed by Pearson's w 2 test. Univariate analysis results for LV systolic and diastolic function parameters were also further confirmed by multivariate analyses controlling for gender, age, blood pressures, height, weight, body mass index, heart rate, and LV mass index as covariates. Two-tailed Po0.05 was considered statistically significant.
Results
Patient characteristics
The clinical characteristics of the 47 patients with LBBB and 886 patients without LBBB are shown in Table 2 . The LBBB group patients included more women, and who were slightly older and had slightly higher systolic and diastolic blood pressures and wider pulse pressure. However, none of the differences between patient groups with and without LBBB, except with regard to gender were statistically significant. Both groups had similar prevalence of diabetes and history of myocardial infarction.
LV mass and geometry
Comparisons of LV structural characteristics between groups with and without LBBB are shown in Table 3 . All patients had similar diastolic interventricular septal and posterior wall thicknesses and LV internal dimension. Both groups also had similarly elevated mean LV mass, LV mass index (LV mass/BSA), and relative wall thickness. As a result, eccentric or concentric LVH or concentric LV remodelling occurred in 40.4, 34.0, and 4.3%, respectively, of patients with LBBB, and in 46.3, 25.0, and 9.3%, respectively, of patients without LBBB. The LV geometric and LV mass differences between patients with and without LBBB groups were not statistically significant. 
LV systolic function
The comparisons of LV global and regional systolic function parameters between patients with and without LBBB are presented in Tables 4  and 5 , respectively. Compared to the group without LBBB, the LBBB group had significantly lower LV global systolic function indices, including fractional shortening, ejection fraction from linear LV dimension, midwall shortening, and stresscorrected midwall shortening (all Po0.001), as well as lower ejection fraction derived from two-dimensional wall motion scores, lower cardiac index, and lower LV stroke volume (all Po0.05) (see Figure 1) . The LBBB group also had worse LV regional wall systolic function indicated by lower LV wall motion score of all LV wall segments. The wall motion scores of the anterior and inferior interventricular septum and the inferior LV wall were significantly lower in the LBBB group than in the group without LBBB (Po0.05).
LV diastolic function
Comparisons of LV diastolic parameters between groups with and without LBBB are presented in Table 6 . The patient group with LBBB had lower mitral valve peak E velocity, higher mitral valve peak A velocity, lower mitral valve E/A ratio, and longer mitral annulus E-wave deceleration time and isovolumetric relaxation time than the patient group without LBBB. The difference in mitral annulus E/A ratio between two groups was statistically significant (Po0.05). 
Discussion
The present study clarifies the cardiac features associated with LBBB among hypertensive patients with ECG LVH. This study had three main findings. First, the degree of anatomic LVH as derived by direct echocardiographic measurements was virtually identical in patients with or without LBBB. Thus, the ECG criteria used to identify LVH in LIFE study (Cornell voltage QRS duration X2440 mV Â ms or modified Sokolow-Lyon criteria SV1 þ RV5/ RV6 438 mV) were equally applicable to patients with or without LBBB. Second, despite the lack of differences between groups in severity of LVH or in the level of blood pressure or the prevalence of diabetes or overt cardiovascular diseases, patients with LBBB had significantly lower indices of LV global systolic function, due in part to regional dysfunction of the interventricular septum and LV inferior wall. Finally, patients with LBBB also showed a tendency to worse early diastolic LV relaxation compared to patients without LBBB. Abnormal interventricular septal motion has been reported in LBBB patients without hypertension and ECG LVH. 3, [31] [32] [33] In the current study, the echocardiographic appearance of the interventricular septum again showed the characteristic asynchronous motion pattern and decreased motion magnitude. The wall motion score of the inferior LV wall was significantly lower in LBBB patients compared to those without LBBB. The asynchronic contraction and reduced motion of the interventricular septum and inferior LV wall are considered to be the major contributors to the lower indices of global LV systolic function in hypertensive patients with ECG LVH and LBBB. In addition, the resemblance between these findings and those of patients with dilated cardiomyopathy suggests that hypertensive patients with ECG LVH who have LBBB, may be at increased risk of developing consequent heart failure.
The current study also showed that the LBBB group patients had more impaired LV diastolic function. The LBBB group showed lower peak E-wave peak velocity, higher A-wave peak velocity, lower mitral valve E/A ratio, and longer IVRT and E-wave deceleration time. The mean mitral annulus E/A ratio of the LBBB patient group was statistically significantly lower than that of the patients without LBBB (P ¼ 0.01). In multiple linear regression analysis with LBBB as indicator variable, together with relevant covariates (age, height, weight, systolic and diastolic blood pressure, and body mass index), the presence of LBBB was independently associated with lower mean mitral E/A ratio than in patients without LBBB (Po0.05). The differences in IVRT and E-wave deceleration time between patients with and without LBBB were not statistically significant in either univariate analyses or in multivariate analyses with the above covariates. One explanation could be that the indicators of LV diastolic function used in this study were not as sensitive and specific as some newer techniques, such as colour flow propagation and Doppler tissue imaging, to identify subtle changes in LV filling. 34 
Conclusions
The present study identifies a strong association between LBBB and LV systolic dysfunction in hypertensive patients with ECG LVH, despite lack of differences between patient groups with and without LBBB in clinical characteristics, degree of echocardiographic LVH, or presence of coexisting diseases. Among hypertensive patients at high risk because of ECG LVH, the presence of LBBB identifies individuals with significantly worse LV global and regional systolic function and evidence of impaired LV relaxation, who may thereby be likely to have an especially high rate of clinical events.
